Synpromics, Solid targeting DMD with transcription promoters
By Jaime De Leon | Sep 20, 2017 | 10:46 PM GMT
Synpromics Ltd. (Edinburgh, U.K.) will provide Solid Biosciences LLC (Cambridge, Mass.) access to muscle-selective synthetic DNA transcription promoter candidates based on Synpromics' PromPT platform which will be used
Read the full 280 word article
User Sign In
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury